Literature DB >> 23430511

Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell lines.

Vincenza Rita Lo Vasco1, Martina Leopizzi, Caterina Chiappetta, Chiara Puggioni, Claudio Di Cristofano, Carlo Della Rocca.   

Abstract

The definition of the number and nature of signal transduction pathways networking in the pathogenesis of osteosarcoma raised great interest. Intracellular calcium ions are important second messengers implicated in the control of cell death. The calcium concentration is regulated by signal transduction pathways, including the Phosphoinositides (PI) signaling. Phosphatydil inositol (4,5) bisphosphate (PIP2) is critical for many cellular activities. The levels of PIP2 are regulated by means of Phosphoinositide-specific Phospholipase C (PI-PLC) family of enzymes. We delineated the panel of expression of PI-PLC enzymes in four human osteosarcoma cell lines. In MG-63 cell line, PI-PLC β1, β2, β3, β4, γ1, γ2, δ1, δ3 and ε resulted expressed. In 143B cell line, PI-PLC β1, β2, β3, β4, γ1, γ2, δ1, δ3 and ε were expressed. In SaOS-2 cell line, PI-PLC β1, β3, β4, γ1, γ2, δ1, δ3, ε and η1. In Hs888 cell line, PI-PLC β1, β3, β4, γ1, δ1, δ3, δ4, ε and η1 the administration of U-73122 to cultures briefly modifies the levels of PI-PLC transcripts. The obtained complete expression panel of PI-PLC isoforms will be a useful tool for further functional studies about the role of the PI signal transduction pathway in osteosarcoma.

Entities:  

Year:  2013        PMID: 23430511      PMCID: PMC3660692          DOI: 10.1007/s12079-013-0194-6

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  31 in total

Review 1.  PLC regulation: emerging pictures for molecular mechanisms.

Authors:  Tom D Bunney; Matilda Katan
Journal:  Trends Biochem Sci       Date:  2010-10-01       Impact factor: 13.807

Review 2.  Multiple forms of phosphoinositide-specific phospholipase C and different modes of activation.

Authors:  S G Rhee; H Kim; P G Suh; W C Choi
Journal:  Biochem Soc Trans       Date:  1991-04       Impact factor: 5.407

3.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

4.  Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts.

Authors:  Chih-Hsin Tang; Rong-Sen Yang; Wen-Mei Fu
Journal:  J Biol Chem       Date:  2005-04-15       Impact factor: 5.157

5.  Childhood cancer survival trends in Europe: a EUROCARE Working Group study.

Authors:  Gemma Gatta; Riccardo Capocaccia; Charles Stiller; Peter Kaatsch; Franco Berrino; Monica Terenziani
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

6.  Osteosarcoma.

Authors:  Richard Gorlick; Chand Khanna
Journal:  J Bone Miner Res       Date:  2010-04       Impact factor: 6.741

7.  Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line.

Authors:  Takato Takenouchi; Kazumasa Ogihara; Mitsuru Sato; Hiroshi Kitani
Journal:  Biochim Biophys Acta       Date:  2005-08-15

8.  Osteosarcoma cell-calcium signaling through tissue factor-factor VIIa complex and factor Xa.

Authors:  Valéry Daubie; Robert De Decker; Charles Nicaise; Roland Pochet
Journal:  FEBS Lett       Date:  2007-05-08       Impact factor: 4.124

9.  Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption.

Authors:  Zsuzsanna Kertész; Dávid Gyori; Szandra Körmendi; Tünde Fekete; Katalin Kis-Tóth; Zoltán Jakus; Georg Schett; Eva Rajnavölgyi; Csaba Dobó-Nagy; Attila Mócsai
Journal:  Eur J Clin Invest       Date:  2011-07-12       Impact factor: 4.686

10.  Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.

Authors:  David W Leung; Chris Tompkins; Jim Brewer; Alexey Ball; Mike Coon; Valerie Morris; David Waggoner; Jack W Singer
Journal:  Mol Cancer       Date:  2004-05-13       Impact factor: 27.401

View more
  7 in total

1.  Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Chiara Puggioni; Carlo Della Rocca; Rita Businaro
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

2.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

3.  Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines.

Authors:  V R Lo Vasco; M Leopizzi; C Della Rocca
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

4.  Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca
Journal:  J Cell Commun Signal       Date:  2014-07-30       Impact factor: 5.782

5.  Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Authors:  Jordan Ayers; Rowan J Milner; Galaxia Cortés-Hinojosa; Alberto Riva; Sandra Bechtel; Bikash Sahay; Matthew Cascio; Amandine Lejeune; Keijiro Shiomitsu; Carlos Souza; Oscar Hernandez; Marc Salute
Journal:  J Vet Diagn Invest       Date:  2021-01-15       Impact factor: 1.279

6.  U-73122 reduces the cell growth in cultured MG-63 ostesarcoma cell line involving Phosphoinositide-specific Phospholipases C.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Valeria Di Maio; Carlo Della Rocca
Journal:  Springerplus       Date:  2016-02-24

7.  Charge Shielding of PIP2 by Cations Regulates Enzyme Activity of Phospholipase C.

Authors:  Jong Bae Seo; Seung-Ryoung Jung; Weigang Huang; Qisheng Zhang; Duk-Su Koh
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.